Whalegun
Home

Peter Blume-Jensen, President and CEO: Acrivon Therapeutics ACRV Planned sale · Filed 08/25

Trade details

Type
Planned sale notice
Stock
Acrivon Therapeutics ACRV
Person
Peter Blume-JensenPresident and CEO
Planned sale date
26/08/25
Filed
26/08/25

More to sell after $3,443 in 3 months

Acrivon Therapeutics trades, last 26 weeks

What else happened in Acrivon Therapeutics around then

Filed or reported within 30 days of the trade day · 07/26~09/24

Peter Blume-Jensen's recent trades

  • Peter Blume-Jensen

    BuyAcrivon Therapeutics

    $82.3K

    Filed 01/16

Peter Blume-Jensen, CEO — plans to sell 14,036 sh of Acrivon Therapeutics ACRV · $30.6K · around 08/25 | Whalegun